The 56 references in paper Natalia Silanteva Konstantinovna, Tatev Agababian Artakovna, Tatyana Berezovskaya Pavlovna, Olga Grishina Gennadievna, Наталья Силантьева Константиновна, Татев Агабабян Артаковна, Татьяна Березовская Павловна, Ольга Гришина Геннадьевна (2014) “КТ-оценка эффектов химио- и лучевой терапии злокачественных опухолей // CT Assessment of Tumor Response to Chemoand Radiotherapy” / spz:neicon:medvis:y:2014:i:6:p:59-74

1
Cancer Incidence in Five Continents Vol. IX. IARC Scientific Publication No. 160. Eds M.P. Curado, B. Edwards, H.R. Shin et al. Lyon: IARC, 2007. 896 p.
(check this in PDF content)
2
Malignancies in Russia in 2012 (morbidity and mortality). Ed. By Kaprin A.D., Starinskij V.V., Petrova G.V. М.: Hertzen Moscow Oncology Research Institute, 2014. 250 p.
(check this in PDF content)
3
Patel J. D., Krilov L., Adams S. et al. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J. Clin. Oncol. 2014; 32 (2): 129–160.
(check this in PDF content)
4
Rusakov I.G. Word from editor. Onkologija segodnja. 2013; 2 (2): 1. (In Russian)
(check this in PDF content)
5
Sedyh S.A., Samratova S.S., Smirnov A.K. Computed Tomography in assessment of the effectiveness of treatment of esophageal cancer. Rossijskiy oncologicheskiy zhurnal.1998; 1: 34–36. (In Russian)
(check this in PDF content)
6
Sahani D.V., Kalva S.P., Hamberg L.M. et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology. 2005; 234 (3): 785–792.
(check this in PDF content)
7
Gwyther S.J., Schwartz L. How to assess anti:tumor efficacy by imaging techniques. Eur. J. Cancer. 2008; 44: 39–45.
(check this in PDF content)
8
Titova L.N., Skoropad V.Yu., Gulidov I.A. et al. Palliative radiation therapy for patients with loco:regional recurrence and metastasis of gastric cancer. Sibirskiy oncologicheskiy zhurnal. 2011; 2: 32–38. (In Russian)
(check this in PDF content)
9
Silanteva N.K., Agababian T.A., Skoropad V.Yu. et al. Experience of MSCT for the assessment of response after chemo:radiotherapy in gastric cancer. Meditsinskaya vizualizatsia. 2011; 3:112–124. (In Russian)
(check this in PDF content)
10
Skvortsova T.Yu., Brodskaya Z.L., Savintseva Zh. I., Gurchin A.F. Imaging challenges in the assessment of posttreatment gliomas and opportunities to improve the accuracy of diagnosis using PET with [11С] methionine. Lucevaya diagnostika i terapiya. 2014; 2 (5): 5–16. (In Russian)
(check this in PDF content)
11
Saini D.C. Radiologic measurement of tumor size in clinical trials: past, present, and future. Am. J. Roentgenol. 2001; 176: 333–334.
(check this in PDF content)
12
Figueiras R.G., Padhani A.R., Goh V.J., et al. Novel oncologic drugs: what they do and how they affect images. RadioGraphics. 2011; 31 (7): 2059–2091.
(check this in PDF content)
13
Collin V.P., Loeffler R.K., Tivey H. Observations on growth rates of human tumours. Am. J. Roentgenol. 1956; 76: 988.
(check this in PDF content)
14
Spratt J.S., Spratt T.L. Rates of growth of pulmonary metastases and host survival. Ann. Surg. 1964; 159: 161.
(check this in PDF content)
15
Husband J.E. Diagnostic techniques: their strengths and weaknesses. Br. J. Cancer. 1980; 41 (Suppl. 4): 21.
(check this in PDF content)
16
Husband J.E., Hawkes B.S., Peckham M.J. CT estimations of mean attenuation values and volume in testicular tumors: a comparison with surgical and histologic findings. Radiology. 1982; 144: 553.
(check this in PDF content)
17
Miller A.B., Hooqstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981; 47 (1): 207–214.
(check this in PDF content)
18
Therasse P., Arbuck S.G., Eisenhauer E.A. et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000; 92 (3): 205–216.
(check this in PDF content)
19
Suzuki C., Jacobsson H., Hatschek T. et al. Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics. 2008; 28 (2): 329–344.
(check this in PDF content)
20
Lange E.E., Fechner R.E., Spaulding C.A., Edge S.B. Rectal carcinoma treated by preoperative irradiation: MR imaging and histopathologic correlation. Am. J. Roentgenol. 1992; 158: 287–292.
(check this in PDF content)
21
Matsuda T. Clinical trials in Japan: emphasis on RF heating of deep–seated cancers. 6th International Congress on Hyperthermic Oncology: plenary and symposia lectures. Tucson, Arizona, 1992. 31–37.
(check this in PDF content)
22
Choi H., Charnsangavej C., Faria S.C. et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J. Clin. Oncol. 2007; 25 (13): 1753–1759.
(check this in PDF content)
23
Vassiliev P.V., Yudin A.L. Clinical value of the contrast enhanced multislice X:ray Computed Tomography in controlling results of the treatment in patients with carcinoma of the larynx or hypopharynx. Meditsinskaya vizualizatsia. 2009; 4: 80–89. (In Russian)
(check this in PDF content)
24
Husband J.E. Monitoring tumor response. Eur. Radiol. 1996; 6: 775–785.
(check this in PDF content)
25
Takahashi M., Hiraoka M., Akuta K. et al. Clinical experience of hyperthermia combined with radiotherapy. Meditsinskaya radiologia. 1988. 33 (12): 25–31. (In Russian)
(check this in PDF content)
26
Kajiura Y., Yamashita K., Ogino T. et al. Local response of hyperthermia for deep seated tumours. Proceedings of the 3rd Annual Meeting of the Japanese Society of Hipyrthermic Oncology. Osaka, Japan, 1986. 293–294.
(check this in PDF content)
27
Skoropad V.Yu., Berdov B.A., Titova L.N. et al. Long:term neoadjuvant chemoradiotherapy followed by D2 gastrectomy in patients with locally advanced gastric cancer. Rossiskiy oncologicheskiy zhurnal. 2010; 4: 10–15. (In Russian)
(check this in PDF content)
28
Bruix J., Sherman M., Llovet J.M. et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barselona:2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 2001; 35: 421–430.
(check this in PDF content)
29
Lencioni R., Llovet J.M. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin. Liver Dis. 2010; 30: 52–60.
(check this in PDF content)
30
Kudo M., Kubo S., Takayasu K. et al. for The Liver Cancer Study Group of Japan (Committee for Response Evaluation Criteria in Cancer of the Liver, Liver Cancer Study Group of Japan). Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version). Hepatol. Res. 2010; 40: 686–692.
(check this in PDF content)
31
Choi H., Charnsangavej C., de Castro Faria S. et al. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantative analysis correlated with FDG PET findings. Am. J. Roentgenol. 2004; 183: 1619–1628.
(check this in PDF content)
32
Tochetto S.M., Rezai P., Rezvani M. et al. Does multidetector CT attenuation change in colon cancer liver metastases treated with 90Y help predict metabolic activity at FDG PET? Radiology. 2010; 255: 154–172.
(check this in PDF content)
33
Stacchiotti S., Collini P., Messina A. et al. High grade soft:tissue sarcomas: tumor response assessment – pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology. 2009; 251: 447–456.
(check this in PDF content)
34
Smith A.D., Lieber M.L., Shah S.N. Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast:enhanced CT. Am. J. Roentgenol. 2010; 194: 157–165.
(check this in PDF content)
35
Smith A.D., Shah S.N., Rini B.I. et al. Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. Am. J. Roentgenol. 2010; 194 (6): 1470–1478.
(check this in PDF content)
36
Kang H., Lee H.Y., Lee K.S. Kim J.H. Imaging:based tumor treatment response evaluation: review of conventional, new, and emerging concepts. Korean J. Radiol. 2012; 13 (4): 371–390.
(check this in PDF content)
37
Lee H.Y., Lee K.S., Hwang H.S. et al. Molecularly targeted therapy using bevacizumab for non:small cell lung cancer: a pilot study for the new CT response criteria. Korean J. Radiol. 2010; 11: 618–626.
(check this in PDF content)
38
Lee H.Y., Lee K.S., Ahn M.J. et al. New CT response criteria in non:small cell lung cancer: proposal and application in EGFR tyrosine kinase inhibitor therapy. Lung Cancer. 2011; 73: 63–69.
(check this in PDF content)
39
Hamaoka T., Costelloe C.M., Madewell J.E. et al. Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone:only metastatic breast cancer. Br. J. Cancer. 2010; 102: 651–657.
(check this in PDF content)
40
Glazer H.S., Lee J.K.T., Levitt R.G. et al. Radiation fibrosis: differentiation from recurrent tumour by MR imaging. Radiology. 1985; 156: 721.
(check this in PDF content)
41
Lemmi M.A., Fletcher B.D., Marina N.M. et al. Use of MR imaging to assess results of chemotherapy for Ewing’s sarcoma. Am. J. Roentgenol. 1990; 155: 343.
(check this in PDF content)
42
Hill M., Cunningham D., MacVicar D. et al. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma. J. Clin. Oncol. 1993; 11: 2273.
(check this in PDF content)
43
Hawnaur J.M., Johnson R.J., Buckley C.H. et al. Staging, volume estimation and assessment of nodal status in carci noma of the cervix: comparison of magnetic resonance imaging with surgical findings. Clin. Radiol. 1994; 49: 443.
(check this in PDF content)
44
Sergeev N.I., Kotlyarov P.M., Solodkiy V.A., Ovchinnikov V.I. Magnetic:rezonance tomography in an estimation of efficiency of chemotherapy and radiotherapy at metastasis disease of a spine and bone pelvis. Meditsinskaya vizualizatsia. 2013; 1: 109–114. (In Russian)
(check this in PDF content)
45
Tsien C., Cao Y., Chenevert T. Clinical applications for diffusion magnetic resonance imaging in radiotherapy. Semin. Radiat. Oncol. 2014; 24 (3): 218–226.
(check this in PDF content)
46
Rubtsova N.A., Puzakov K.V. Role of magnetic resonance imaging in the diagnosis of rectal cancer, the planning of and evaluation of the efficiency of its treatment. Rossiskiy oncologicheskiy zhurnal. 2012; 3: 42–45. (In Russian)
(check this in PDF content)
47
Kim H.S., Kim C.K., Park B.K. et al. Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion:weighted MR imaging. J. Magn. Reson. Imaging. 2013; 37 (1): 187–193.
(check this in PDF content)
48
Mungai F., Pasquinelli F., Mazzoni L.N. et al. Diffusion:weighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastases. Radiol. Med. 2014; 119 (8): 625–633.
(check this in PDF content)
49
Delbeke D. Oncological applications of FDG PET imaging. J. Nucl. Med. 1999; 40 (10): 1706–1715.
(check this in PDF content)
50
Young H., Baum R., Cremerius U. et al. Measurement of clinical and subclinical tumour response using [18F]:fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur. J. Cancer. 1999; 35 (13): 1773– 1782.
(check this in PDF content)
51
Gwyther S.J. Current standards for response evaluation by imaging technique. Eur. J. Nucl. Med. Mol. Imaging. 2006; 33 (Suppl. 13): 11–15.
(check this in PDF content)
52
Shankar L.K., Hoffman J.M., Bacharach S. et al. Consensus recommendations for the use of 18FFDG PET as an indi cator of therapeutic response in patients in National Cancer Institute Trials. J. Nucl. Med. 2006; 47 (6): 1059–1066.
(check this in PDF content)
53
Weber W.A., Figlin R. Monitoring cancer treatment with PET/CT: does it make a difference? J. Nucl. Med. 2007; 48 (Suppl. 1): 36S–44S.
(check this in PDF content)
54
Khomutova E.Yu., Ignatjev Yu.T., Philippova Yu.G. CT:perfusion in assessment of rectal cancer treatment effectiveness. Diagnosticheskaja i interventsionnaya radiologiya. 2010; 1 (4): 29–33. (In Russian)
(check this in PDF content)
55
Imaging tumor response to therapy. Ed. by Aglietta M., Regge D. Milan: Springer:Verlag Italia, 2012. 157 p.
(check this in PDF content)
56
Gelezhe P.V., Morozov S.P., Mandelblat Yu.E., Libson E. I. What’s new in cancer evaluation criteria in medical imaging: RECIST vs PERCIST? Lucevaya diagnostika I terapia. 2014; 2 (5): 28–36. (In Russian)
(check this in PDF content)